Phase I Study of QLS1510 Tablets in Healthy Participants
Clinical trial NCT07760077 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07760077
- Sponsor
- Shanghai Qilu Pharmaceutical Research and Development Center LTD
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-30
- Primary completion
- 2027-01-30
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.